邻近类别 報告 [0/1] 專利 [0/20] 类别统计 近3年内发表的文件:1(3.23%) 含全文笔数:31(100.00%) 文件下载次数统计 下载大于0次:31(100.00%) 下载大于100次:31(100.00%) 全文下载总次数:25832(100.00%) 最后更新时间: 2024-11-28 15:35 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Rosmarinic acid interferes with inf... Rosmarinic acid exhibits broad anti... A novel flavivirus entry inhibitor,... A novel, potent, and orally bioavai... Development of robust genotype 1a h... Mutagenesis of dengue virus protein... A potent, selective, and orally bio... Stimulatory actions of a novel thio... In vitro and in vivo studies of a p... A novel dengue virus inhibitor, BP1...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-31 / 31. (共1页) 1  每页显示[10|25|50]项目

日期	题名	關聯
2022-08	Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels	Journal of Microbiology, Immunology, and Infection. 2022 Aug;55(4):598-610.
2020-12	Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
2019-12	A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses	Antiviral Research. 2019 Dec;172:Article number 104636.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2018-09	Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication	Journal of Virological Methods. 2018 Sep;259:10-17.
2017-12	Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels	Journal of Cellular Physiology. 2017 Dec;232(12):3409-3421.
2017-06	Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments	Journal of Virology. 2017 Jun;91(12):Article number e01836-16.
2017-01	A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide	Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
2016-07	In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71	Journal of Antimicrobial Chemotherapy. 2016 Jul;71(7):1922-1932.
2014-01	A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease	Antimicrobial Agents and Chemotherapy. 2014 Jan;58(1):110-119.
2013-02	Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems	Antimicrobial Agents and Chemotherapy. 2013 Feb; 57(2):723-733.
2012-01	Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor	Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):44-53.
2011-04	Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer	Investigational New Drugs. 2011 Apr;29(2):195-206.
2011-04	Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors	Bioorganic and Medicinal Chemistry Letters. 2011 Apr;21(7):1948-1952.
2011-01	Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay	Antimicrobial Agents and Chemotherapy. 2011 Jan;55(1):229-238.
2011-01	BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities	Cancer Science. 2011 Jan;102(1):182-191.
2010-10	Modulation of microglial immune responses by a novel thiourea derivative	Chemico-Biological Interactions. 2010 Oct;188(1):228-236.
2010-09-01	Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors	Bioorganic and Medicinal Chemistry. 2010 Sep ;18(17):6414-6421.
2009-11-01	Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors	Bioorganic and Medicinal Chemistry Letters. 2009 Nov 1;19(21):6063-6068.
2009-08-01	Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors	Bioorganic and Medicinal Chemistry Letters. 2009 Aug 1;19(15):4134-4138.
2009-07	Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71	Antimicrobial Agents and Chemotherapy. 2009 Jul;53(7):2740-2747.
2009-04-01	Design, synthesis, and anti-HCV activity of thiourea compounds	Bioorganic and Medicinal Chemistry Letters. 2009 Apr 1;19(7):1950-1955.
2008-10-15	Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma	Bioorganic and Medicinal Chemistry Letters. 2008 Oct 15;18(20):5676-5679.
2008-05	Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants	Journal of Biomedical Science. 2008 May;15(3):291-300.
2005-10-01	Synthesis and antipicornavirus activity of (R)- and (S)-1-[5-(4 '-chlorobiphenyl-4-yloxy)-3-methylpentyl]-3-pyridin-4-yl-imidazolidin-2-one	Bioorganic and Medicinal Chemistry Letters. 2005 Oct;15(19):4206-4211.
2005-05-19	Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives	Journal of Medicinal Chemistry. 2005 May;48(10):3522-3535.
2004-10-18	Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones	Bioorganic and Medicinal Chemistry Letters. 2004 Oct;14(20):5051-5056.
2004-09	Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone	Antimicrobial Agents and Chemotherapy. 2004 Sep;48(9):3523-3529.
2004-05-17	Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors	Bioorganic and Medicinal Chemistry Letters. 2004 May;14(10):2519-2525.
2004-03-08	Synthesis and in vitro cytotoxicity of 5-substituted 2-cyanoimino-4-imidazodinone and 2-cyanoimino-4-pyrimidinone derivatives	Bioorganic and Medicinal Chemistry Letters. 2004 Mar;14(5):1169-1172.
2002-04-11	Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors	Journal of Medicinal Chemistry. 2002 Apr;45(8):1644-1655.

显示项目1-31 / 31. (共1页) 1  每页显示[10|25|50]项目